News of Note—Heat-stable TB shot, measles outbreak and more


Here is some other vaccine news of note for the week:

> Scientists have started phase 1 testing of ID93, a freeze-dried, temperature-stable recombinant tuberculosis vaccine candidate developed at the Infectious Disease Research Institute. NIH release

> The number of confirmed cases of measles in western Washington has grown to 36, as health officials have declared a state of emergency and are urging immunization. NPR article


Veeva 2020 Unified Clinical Operations Survey

We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more robust and insightful than the last. Please take a moment to share your opinion in this 10-minute survey. All qualified respondents will be entered to win a $500 Amazon gift card.

> A new poll by South Nassau Communities Hospital showed that parents are aware of the HPV vaccine but that some have no plans—or are unsure—whether they’ll have their children immunized. Newsday article

Suggested Articles

Amid the COVID-19 pandemic, many teams of researchers are working on potential vaccines. We asked experts to assess progress—and point out challenges.

Fujifilm says it is prepared to ramp up production of Avigan for any country that wants to try it as a potential treatment for COVID-19.

Pfizer posted positive top-line results for a trial of its 20-valent pneumococcal vaccine, potentially setting up a filing by the end of 2020.